gp10基因的原核表达及其联合异烟肼的体外抗结核菌活性

doi:10.13481/j.1671-587x.20150322

吉林大学学报(医学版) ›› 2015, Vol. 41 ›› Issue (03): 548-552.doi: 10.13481/j.1671-587x.20150322

gp10基因的原核表达及其联合异烟肼的体外抗结核菌活性

彭蔚, 黎友伦, 冯燕梅, 彭丽

重庆医科大学附属第一医院呼吸内科, 重庆 400016

收稿日期:2014-11-09 发布日期:2015-08-01
通讯作者: 彭丽,副主任医师(Tel:023-89012016,E-mail:pli1228@163.com) E-mail:pli1228@163.com
作者简介:彭蔚(1988-),女,湖南省长沙市人,在读医学硕士,主要从事结核病新药研发方面的研究。
基金资助:
重庆市卫计委面上项目资助课题(2012-2-006);国家卫生与计划生育委员会临床重点专科建设项目资助课题(卫办医政函[2012]649号)

Prokaryotic expression of gp10 gene and antibacterial activity of gp10 gene combined with isoniazid to Mycobacterium tuberculosis in vitro

PENG Wei, LI Youlun, FENG Yanmei, PENG Li

Department of Respiratory Medicine, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China

Received:2014-11-09 Published:2015-08-01

摘要/Abstract

摘要：

目的:原核表达分枝杆菌噬菌体D29内溶素gp10蛋白,检测其单用及与异烟肼联合对体外结核菌的抗菌活性。方法:采用PCR法从分枝杆菌噬菌体D29基因组中扩增gp10基因,克隆至原核表达载体pET32a(+),经双酶切和测序鉴定正确的重组质粒转化至大肠杆菌BL21(DE3)中表达目的蛋白。采用微量刃天青显色法测定gp10蛋白对结核分枝杆菌(MTB)标准株H₃₇Rv和临床分离耐多药株的最低抑菌浓度(MIC),同时观察其与异烟肼联用对H₃₇Rv的部分抑菌浓度指数(FICI)。结果:PCR 扩增获得长1 479 bp的gp10基因,重组质粒pET32a(+)-gp10经EcoRⅠ和NotⅠ双酶切获得长约5 900和1 479 bp的条带,gp10基因测序结果与GenBank中基因序列一致,并表达相对分子质量约75 200的目的蛋白。重组蛋白gp10对MTB H₃₇Rv和临床分离耐多药株的MIC为256 mg·L^-1,其与异烟肼联用对H₃₇Rv的 FICI为0.5。结论:成功表达重组蛋白gp10,gp10对体外MTB H₃₇Rv和临床耐多药株均表现出良好抗菌活性,其与异烟肼联用对体外H₃₇Rv表现出协同效应。

关键词: gp10蛋白, 异烟肼, 结核杆菌, 抗菌活性

Abstract:

Objective To express the mycobacteriophage D29 lysin gp10 in prokaryotic cells, and to investigate its antibacterial activities of alone and combined with isoniazid(INH)to Mycobacterium tuberculosis(MTB) in vitro. Methods The gp10 gene was amplified by PCR using the genome of mycobacteriophage D29 as a template and cloned into pET32a(+) vector. The constructed vector pET32a(+)-gp10 was identified by restriction enzyme digestion and nucleotide sequencing, and transformed to E.coli BL21(DE3) for expression. The minimal inhibitory concentration(MIC) of recombinant protein gp10 was detected by resazurin drugs combination microtiter assay (REDCA) for MTB standard strain H₃₇Rv and clinical isolate of multidrug-resistant MTB, the fractional inhibitory concentration index(FICI) was used to the antibacterial activity between INH and gp10 in MTB H₃₇Rv. Results The gp10 at a length of 1 479 bp was amplified by PCR, the recombinant plasmid pET32a(+)-gp10 was digested by EcoRⅠ and NotⅠ for 5 900 and 1 479 bp bands, gp10 sequence analysis was consistent with the sequence in GenBank, and it expressed a target protein with a relative molecular mass about 75 200. The MICs of recombinant protein gp10 were 256 mg·L^-1 against standard strain H₃₇Rv and clinical isolate of multidrug-resistant MTB. The FICI of combined INH and gp10 was 0.5 for MTB H₃₇Rv. Conclusion The recombinant protein gp10 is expressed successfully, and it shows good antibacterial activity against MTB H₃₇Rv and clinical isolate of multidrug-resistant MTB. Synergism in MTB H₃₇Rv is observed with gp10 combined with INH in vitro.

Key words: gp10 protein, isoniazid, Mycobacterium tuberculosis, antibacterial activity

中图分类号:

R378

彭蔚, 黎友伦, 冯燕梅, 彭丽. gp10基因的原核表达及其联合异烟肼的体外抗结核菌活性[J]. 吉林大学学报(医学版), 2015, 41(03): 548-552.

PENG Wei, LI Youlun, FENG Yanmei, PENG Li. Prokaryotic expression of gp10 gene and antibacterial activity of gp10 gene combined with isoniazid to Mycobacterium tuberculosis in vitro[J]. Journal of Jilin University Medicine Edition, 2015, 41(03): 548-552.

参考文献

[1] O'Flaherty S, Ross RP, Coffey A. Bacteriophage and their lysins for elimination of infectious bacteria[J]. FEMS Microbiol Rev, 2009, 33(4):801-819.

[2] 杨文慧, 于龙, 胡凌飞, 等. 分枝杆菌噬菌体D29裂解酶基因的表达与鉴定[J]. 军事医学科学院院刊, 2009, 33(2):113-116.

[3] 熊玉霞, 杨致邦, 于拽拽, 等. 分枝杆菌噬菌体D29裂解酶gp10的原核表达及抗脓肿分枝杆菌活性[J]. 中国生物制品学杂志, 2011, 24(11):1269-1272.

[4] Bhusal Y, Shiohira CM, Yamane N. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis[J]. Int J Antimicrob Agents, 2005, 26(4):292-297.

[5] Campanerut PA, Ghiraldi LD, Spositto FL, et al. Rapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assay[J]. J Antimicrob Chemother, 2011, 66(5):1044-1046.

[6] Martin A, Pasch F, Docx S, et al. Multicentre laboratory validation of the colorimetric redox indicator(CRI) assay for the rapid detection of extensively drug-resistant(XDR)Mycobacterium tuberculosis[J]. J Antimicrob Chemother, 2011, 66(4):827-833.

[7] Rodriguez-Cerrato V, Garcia P, Del Prado G, et al. In vitro actions of LytA, the major pneumococcal autolysin. With two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic -susceptible and -resistant Streptococcus pneumoniae strains [J]. J Antimicrob Chemother, 2007, 60(5):1159-1162.

[8] Drago L, Nicola1 L, Rodighiero V, et al. Comparative evaluation of synergy of combinations of β-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae[J]. J Antimicrob Chemother, 2011, 66(4):845-849.

[9] Caleffi-Ferracioli KR, Maltempe FG, Siqueira VL, et al. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method[J]. Tuberculosis, 2013, 93(6):660-663.

[10] Fenton M, Ross P, McAuliffe O, et al. Recombinant bacteriophage lysins as antibacterials[J]. Bioeng Bugs, 2010, 1(1):9-16.

[11] Lim JA, Shin H, Heu S, et al. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria[J]. J Microbiol Biotechnol, 2014, 24(6):803-811.

[12] Lai MJ, Lin NT, Hu A, et al. Antibacterial activity of Acinetobacter baumannii phage ΦAB2 endolysin(LysAB2) against both gram-positive and gram-negative bacteria[J]. Appl Microbiol Biotechnol, 2011, 90(2):529-539.

[13] Payne KM, Hatfull GF. Mycobacteriophage endolysins:diverse and modular enzymes with multiple catalytic activities[J]. PLoS One, 2012, 7(3):e34052.

[14] Lakshmanan M, Xavier AS. Bedaquiline—The first ATP synthase inhibitor against multidrug resistant tuberculosis[J]. J Young Pharm, 2013, 5(4):112-115.

[15] Morbidoni HR, Morbidoni HR. Recycling and refurbishing old antitubercular drugs:the encouraging case of inhibitors of mycolic acid biosynthesis[J]. Expert Rev Anti Infect Ther, 2013, 11(4):429-440.

[16] Schuch R, Lee HM, Schneider BC, et al. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia[J]. J Infect Dis, 2014, 209 (9):1469-1478.

gp10基因的原核表达及其联合异烟肼的体外抗结核菌活性

Prokaryotic expression of gp10 gene and antibacterial activity of gp10 gene combined with isoniazid to Mycobacterium tuberculosis in vitro

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

Metrics

本文评价

推荐阅读 0